Molecular skin fluorescence imaging: A tool for evaluating early melanoma development

Area of Science:

• Dermatology
• Medical Imaging
• Oncology

Background:

• Melanoma diagnosis relies on visual inspection and biopsy, which can be invasive.
• Early detection of premalignant changes is crucial for effective melanoma treatment.
• Molecular imaging offers a potential non-invasive approach to assess cellular changes.

Purpose of the Study:

• To develop and evaluate an in vivo molecular skin fluorescence imaging (mSFI) technique for melanoma diagnosis.
• To assess the ability of mSFI to detect premalignant tissue remodeling associated with melanoma.
• To identify a diagnostic threshold for differentiating melanoma from benign nevi using mSFI.

Main Methods:

• Developed mSFI utilizing a fluorescent peptide (ORL-1) targeting αvβ3 integrin.
• Imaged the microenvironment proximal to skin lesions in human subjects.
• Established a cutoff score for lesion classification based on fluorescence intensity.

Main Results:

• The mSFI method demonstrated 100% sensitivity and 95.7% specificity in differentiating melanomas from nonmelanoma nevi.
• A cutoff score of 7 was established for distinguishing malignant from benign lesions.
• The technique successfully identified dysplastic nevi with melanoma development potential.

Conclusions:

• In vivo molecular skin fluorescence imaging (mSFI) is a promising non-invasive tool for melanoma diagnosis.
• mSFI can detect early molecular changes and tissue remodeling indicative of melanoma.
• This imaging approach enhances diagnostic accuracy for melanoma and premalignant lesions.